Role of PD-L1/PD-1 in the immune response to respiratory viral infections

Microbes and Infection

Volumn 14, Issue 6, 2012, Pages 495-499

  Zdrenghea, Mihnea Tudor ^a   Johnston, Sebastian Lennox ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

B7 DC; B7 H1; PD 1; Viruses

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROGRAMMED DEATH 1 RECEPTOR;

ASTHMA; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; IMMUNOREGULATION; INFECTION SENSITIVITY; LUNG PARENCHYMA; NONHUMAN; PNEUMOVIRUS INFECTION; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; RHINOVIRUS INFECTION; SHORT SURVEY; T LYMPHOCYTE; VIRAL RESPIRATORY TRACT INFECTION;

ANIMALS; ANTIGENS, CD274; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; EPITHELIAL CELLS; HUMANS; INFANT; LUNG; MICE; MICE, INBRED BALB C; PROGRAMMED CELL DEATH 1 RECEPTOR; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS;

RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS;

EID: 84860431971     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.01.002     Document Type: Short Survey

References (70)

1. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A.H., Freeman G.J. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001, 2:261-268.
2. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001, 97:1809-1816.
3. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002, 20:29-53.
4. Coyle A.J., Gutierrez-Ramos J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2001, 2:203-209.
5. Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007, 8:239-245.
6. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000, 192:1027-1034.
7. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001, 193:839-846.
8. Youngnak P., Kozono Y., Kozono H., Iwai H., Otsuki N., Jin H., Omura K., Yagita H., Pardoll D.M., Chen L., Azuma M. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem. Biophys. Res. Commun. 2003, 307:672-677.
9. Ishida Y., Agata Y., Shibahara K., Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992, 11:3887-3895.
10. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151.
11. Nishimura H., Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 2001, 22:265-268.
12. Mazanet M.M., Hughes C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 2002, 169:3581-3588.
13. Brown J.A., Dorfman D.M., Ma F.R., Sullivan E.L., Munoz O., Wood C.R., Greenfield E.A., Freeman G.J. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003, 170:1257-1266.
14. Loke P., Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. U S A 2003, 100:5336-5341.
15. Ishiwata K., Watanabe N., Guo M., Tomihara K., Brumlik M.J., Yagita H., Pardoll D., Chen L., Shin T. Costimulator B7-DC attenuates strong Th2 responses induced by Nippostrongylus brasiliensis. J. Immunol. 2010, 184:2086-2094.
16. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 1999, 5:1365-1369.
17. Gray C.P., Arosio P., Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002, 99:3326-3334.
18. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J., Carreno B.M. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 2002, 32:634-643.
19. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon V.A., Celis E., Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 2002, 8:793-800.
20. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 2003, 197:1083-1091.
21. Iwai Y., Ishida M., Tanaka Y., Okazaki T., Honjo T., Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. U S A 2002, 99:12293-12297.
22. Rodig N., Ryan T., Allen J.A., Pang H., Grabie N., Chernova T., Greenfield E.A., Liang S.C., Sharpe A.H., Lichtman A.H., Freeman G.J. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 2003, 33:3117-3126.
23. Keir M.E., Liang S.C., Guleria I., Latchman Y.E., Qipo A., Albacker L.A., Koulmanda M., Freeman G.J., Sayegh M.H., Sharpe A.H. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006, 203:883-895.
24. Latchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., Kuchroo V.K., Freeman G.J., Sharpe A.H. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. U S A 2004, 101:10691-10696.
25. Matsumoto K., Fukuyama S., Eguchi-Tsuda M., Nakano T., Matsumoto T., Matsumura M., Moriwaki A., Kan-O K., Wada Y., Yagita H., Shin T., Pardoll D.M., Patcharee R., Azuma M., Nakanishi Y., Inoue H. B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma. Biochem. Biophys. Res. Commun. 2008, 365:170-175.
26. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
27. Dong H., Chen X. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell. Mol. Immunol. 2006, 3:179-187.
28. Kaufmann D.E., Walker B.D. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection. Curr. Opin. HIV AIDS 2008, 3:362-367.
29. Velu V., Titanji K., Zhu B., Husain S., Pladevega A., Lai L., Vanderford T.H., Chennareddi L., Silvestri G., Freeman G.J., Ahmed R., Amara R.R. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009, 458:206-210.
30. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., Betts M.R., Freeman G.J., Vignali D.A., Wherry E.J. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009, 10:29-37.
31. Barclay W.S., al-Nakib W., Higgins P.G., Tyrrell D.A. The time course of the humoral immune response to rhinovirus infection. Epidemiol. Infect. 1989, 103:659-669.
32. Henderson F.W., Collier A.M., Clyde W.A., Denny F.W. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 1979, 300:530-534.
33. Hall C.B., Walsh E.E., Long C.E., Schnabel K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 1991, 163:693-698.
34. Chanock R.M., Parrott R.H., Connors M., Collins P.L., Murphy B.R. Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. Pediatrics 1992, 90:137-143.
35. Falsey A.R., Walsh E.E. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J. Infect. Dis. 1998, 177:463-466.
36. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., Auinger P., Griffin M.R., Poehling K.A., Erdman D., Grijalva C.G., Zhu Y., Szilagyi P. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 2009, 360:588-598.
37. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225-1229.
38. Kusel M.M., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L., Sly P.D. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J. Allergy Clin. Immunol. 2007, 119:1105-1110.
39. Jartti T., Kuusipalo H., Vuorinen T., Soderlund-Venermo M., Allander T., Waris M., Hartiala J., Ruuskanen O. Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children. Pediatr. Allergy Immunol. 2010, 21:1008-1014.
40. Jackson D.J., Lemanske R.F. The role of respiratory virus infections in childhood asthma inception. Immunol. Allergy Clin. North. Am. 2010, 30:513-522. (vi).
41. Papadopoulos N.G., Sanderson G., Hunter J., Johnston S.L. Rhinoviruses replicate effectively at lower airway temperatures. J. Med. Virol. 1999, 58:100-104.
42. Papadopoulos N.G., Bates P.J., Bardin P.G., Papi A., Leir S.H., Fraenkel D.J., Meyer J., Lackie P.M., Sanderson G., Holgate S.T., Johnston S.L. Rhinoviruses infect the lower airways. J. Infect. Dis. 2000, 181:1875-1884.
43. Hall C.B., Long C.E., Schnabel K.C. Respiratory syncytial virus infections in previously healthy working adults. Clin. Infect. Dis. 2001, 33:792-796.
44. Zhang L., Peeples M.E., Boucher R.C., Collins P.L., Pickles R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 2002, 76:5654-5666.
45. Mezzetti M., Soloperto M., Fasoli A., Mattoli S. Human bronchial epithelial cells modulate CD3 and mitogen-induced DNA synthesis in T cells but function poorly as antigen-presenting cells compared to pulmonary macrophages. J. Allergy Clin. Immunol. 1991, 87:930-938.
46. Kalb T.H., Chuang M.T., Marom Z., Mayer L. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 1991, 4:320-329.
47. Kalb T.H., Yio X.Y., Mayer L. Human airway epithelial cells stimulate T-lymphocyte lck and fyn tyrosine kinase. Am. J. Respir. Cell Mol. Biol. 1997, 17:561-570.
48. Salik E., Tyorkin M., Mohan S., George I., Becker K., Oei E., Kalb T., Sperber K. Antigen trafficking and accessory cell function in respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 1999, 21:365-379.
49. Oei E., Kalb T., Beuria P., Allez M., Nakazawa A., Azuma M., Timony M., Stuart Z., Chen H., Sperber K. Accessory cell function of airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 287:L318-L331.
50. Kim J., Myers A.C., Chen L., Pardoll D.M., Truong-Tran Q.A., Lane A.P., McDyer J.F., Fortuno L., Schleimer R.P. Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2005, 33:280-289.
51. Papi A., Johnston S.L. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-kappaB and GATA transcription factors. J. Biol. Chem. 1999, 274:30041-30051.
52. Papi A., Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J. Biol. Chem. 1999, 274:9707-9720.
53. Papi A., Stanciu L.A., Papadopoulos N.G., Teran L.M., Holgate S.T., Johnston S.L. Rhinovirus infection induces major histocompatibility complex class I and costimulatory molecule upregulation on respiratory epithelial cells. J. Infect. Dis. 2000, 181:1780-1784.
54. M.T. Zdrenghea, A.G. Telcian, V. Laza-Stanca, C.M. Bellettato, M.R. Edwards, A. Nikonova, M.R. Khaitov, N. Azimi, V. Groh, P. Mallia, S.L. Johnston, L.A. Stanciu, RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells, Eur. Respir. J. (2011) Aug 18 [Epub ahead of print].
55. Telcian A.G., Laza-Stanca V., Edwards M.R., Harker J.A., Wang H., Bartlett N.W., Mallia P., Zdrenghea M.T., Kebadze T., Coyle A.J., Openshaw P.J., Stanciu L.A., Johnston S.L. RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J. Infect. Dis. 2011, 203:85-94.
56. Heidema J., de Bree G.J., De Graaff P.M., van Maren W.W., Hoogerhout P., Out T.A., Kimpen J.L., van Bleek G.M. Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J. Gen. Virol. 2004, 85:2365-2374.
57. de Bree G.J., van Leeuwen E.M., Out T.A., Jansen H.M., Jonkers R.E., van Lier R.A. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J. Exp. Med. 2005, 202:1433-1442.
58. Heidema J., Rossen J.W., Lukens M.V., Ketel M.S., Scheltens E., Kranendonk M.E., van Maren W.W., van Loon A.M., Otten H.G., Kimpen J.L., van Bleek G.M. Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold. J. Immunol. 2008, 181:5551-5559.
59. Piet B., de Bree G.J., Smids-Dierdorp B.S., van der Loos C.M., Remmerswaal E.B., von der Thusen J.H., van Haarst J.M., Eerenberg J.P., ten Brinke A., van der Bij W., Timens W., van Lier R.A., Jonkers R.E. CD8 T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J. Clin. Invest. 2011, 121:2254-2263.
60. Stanciu L.A., Bellettato C.M., Laza-Stanca V., Coyle A.J., Papi A., Johnston S.L. Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J. Infect. Dis. 2006, 193:404-412.
61. Kirchberger S., Majdic O., Steinberger P., Bluml S., Pfistershammer K., Zlabinger G., Deszcz L., Kuechler E., Knapp W., Stockl J. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J. Immunol. 2005, 175:1145-1152.
62. Heinecke L., Proud D., Sanders S., Schleimer R.P., Kim J. Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: in vivo and in vitro studies. J. Allergy Clin. Immunol. 2008, 121:1155-1160.
63. Coyle A.J., Erard F., Bertrand C., Walti S., Pircher H., Le Gros G. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 1995, 181:1229-1233.
64. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., Johnston S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
65. Wark P.A., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur. Respir. J. 2002, 19:68-75.
66. Legg J.P., Hussain I.R., Warner J.A., Johnston S.L., Warner J.O. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 2003, 168:633-639.
67. Makela M.J., Tripp R., Dakhama A., Park J.W., Ikemura T., Joetham A., Waris M., Anderson L.J., Gelfand E.W. Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. J. Allergy Clin. Immunol. 2003, 112:861-869.
68. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., Wright A.L., Martinez F.D. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354:541-545.
69. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 2005, 171:137-141.
70. Singh A.K., Stock P., Akbari O. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 2011, 66:155-162.